Children's Neuroblastoma Cancer Foundation

Browse by Tags

Sorry, but there are no more tags available to filter with.

Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma.

Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma. Pediatr Blood Cancer. 2008 Nov 6; Authors: Drukker CA, Heij HA, Wijnaendts LC, Verbeke JI, Kaspers GJ The anti-Hu syndrome is a well-known paraneoplastic syndrome and may be rarely seen in patients with neuroblastoma. However, it is...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 11-08-2008
Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: A Pediatric Oncology Group study (POG 9376).

Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: A Pediatric Oncology Group study (POG 9376). Pediatr Blood Cancer. 2008 Nov 6; Authors: Geller JI, Wall D, Perentesis J, Blaney SM, Bernstein M PURPOSE: A dose-escalation Phase I study of taxol (paclitaxel...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 11-08-2008
Bilateral adrenal neuroblastoma.

Related Articles Bilateral adrenal neuroblastoma. Pediatr Blood Cancer. 2008 Oct 24; Authors: Pagès PM, Dufour C, Fasola S, Michon J, Boutard P, Gentet JC, Hartmann O BACKGROUND: Bilateral adrenal neuroblastoma is extremely rare. To date, 45 cases have been reported in the literature. PROCEDURES...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 10-28-2008
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group.

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Oct 20; Authors: Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 10-22-2008
Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma-response.

Related Articles Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma-response. Pediatr Blood Cancer. 2008 Oct 14; Authors: Smith AR, Hennessy JM, Heisel Kurth MA, Nelson SC PMID: 18855891 [PubMed - as supplied by publisher]

Posted to Neuroblastoma Research (Weblog) by Anonymous on 10-16-2008
Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma.

Related Articles Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma. Pediatr Blood Cancer. 2008 Oct 6; Authors: Marabelle A, Sapin V, Rousseau R, Periquet B, Demeocq F, Kanold J We report 19 episodes of hypercalcemia in three children treated with 13-cis-retinoic acid...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 10-08-2008
High risk neuroblastoma: A persistent therapeutic challenge.

High risk neuroblastoma: A persistent therapeutic challenge. Pediatr Blood Cancer. 2008 Sep 25; Authors: Garaventa A, Perilongo G PMID: 18819123 [PubMed - as supplied by publisher]

Posted to Neuroblastoma Research (Weblog) by Anonymous on 09-27-2008
Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma.

Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma. Pediatr Blood Cancer. 2008 Sep 25; Authors: Modak S, Cheung NK, Abramson SJ, Price AP PMID: 18819126 [PubMed - as supplied by publisher]

Posted to Neuroblastoma Research (Weblog) by Anonymous on 09-27-2008
Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.

Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer. 2008 Sep 25; Authors: van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hählen K, Dohle GR, van den Heuvel-Eibrink MM BACKGROUND: Although it is accepted that pediatric cancer...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 09-27-2008
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group.

Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Aug 14; Authors: Zage PE, Kletzel M, Murray K, Marcus R, Castleberry R, Zhang Y, London WB, Kretschmar C BACKGROUND: From 1993 to 1995, the...

Posted to Neuroblastoma Research (Weblog) by Anonymous on 08-16-2008

Page 1 of 2 (15 items) 1 2 Next >